(INNS)
SOCAZOLIMAB(INND)
SOKAZOLIMAB(INNC)
IMMUNOGLOBULIN G1-LAMBDA2, ANTI-[HOMO SAPIENS CD274 (PROGRAMMED CELL DEATH 1 LIGAND 1, B7H1, B7-H1, PDL1, PD-L1, PDCD1L1, B7 HOMOLOG 1)], MONOCLONAL ANTIBODY; GAMMA1 HEAVY CHAIN (1-449) [VH (HOMO SAPIENS IGHV1-69*01 (98.0%) -(IGHD) -IGHJ6*01 (94.7%), CDR-IMGT [8.8.12] (26-33.51-58.97-108)) (1-119) - HOMO SAPIENS IGHG1*01 (100%), G1M17,1 (CH1 K120 (216) (120-217), HINGE 1-15 (218-232), CH2 (233-342), CH3 D12 (358), L14 (360) (343-447), CHS (448-449)) (120-449)], (222-214')-DISULFIDE WITH LAMBDA2 LIGHT CHAIN (1'-215') [V-LAMBDA (HOMO SAPIENS IGLV2-23*02 (90.8%)-IGLJ2*01 (100%), CDR-IMGT [9.3.10] (26-34.52-54.90-99)) (1'-109') - HOMO SAPIENS IGLC2*01 (100%) (110'-215')]; DIMER (228-228'':231-231'')-BISDISULFIDE, PRODUCED IN CHINESE HAMSTER OVARY (CHO)-K1SV CELL LINE LACKING THE GLUTAMINE SYNTHETASE GENE (GSKO), GLYCOFORM ALFA(WHO)
SOCAZOLIMABUM(INN)